Personnel Information

写真a

YAMAGUCHI Yuta


Job title

Assistant Professor

Campus Career 【 display / non-display

  • 2025.07
    -
    2025.08
    Institute of Science Tokyo, -, Graduate Schools, Cognitive and Behavioral Medicine, Department of Pharmacology, Visiting Lecturer
  • 2025.09
    -
    Now
    Institute of Science Tokyo, -, Graduate Schools, Cognitive and Behavioral Medicine, Department of Pharmacology, Assistant Professor

External Career 【 display / non-display

  • 2021.04
    -
    2023.03
    Japan Society for the Promotion of Science, Research Fellowships for Young Scientists
  • 2025.09
    -
    Now
    Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Division of Pharmacology, Assistant Professor
 

Published Papers & Misc 【 display / non-display

  1. CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response. 2025.04; 45 (1): 8. ( PubMed, DOI )

  2. Semaphorin 6D tunes amygdalar circuits for emotional, metabolic, and inflammatory outputs. 2024.07; ( PubMed, DOI )

  3. Sema6D forward signaling impairs T cell activation and proliferation in head and neck cancer. 2024.02; 9 (3): ( PubMed, DOI )

  4. Cancer-associated SNRPD3 mutation confers resistance to hypoxia, which is attenuated by DRP1 inhibition. 2024.01; 696 149511. ( PubMed, DOI )

  5. Single-cell analyses and host genetics highlight the role of innate immune cells in COVID-19 severity 2023.04; 55 (5): 753-767. ( PubMed, DOI )

  6. A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients. 2023.01; 120 (4): e2217902120. ( PubMed, DOI )

  7. Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19. 2022.11; 42 (1): 53. ( PubMed, DOI )

  8. DOCK2 is involved in the host genetics and biology of severe COVID-19 2022.09; 609 (7928): 754-760. ( DOI )

  9. The proliferative activity levels of each immune cell population evaluated by mass cytometry are linked to the clinical phenotypes of systemic lupus erythematosus 2022.08; 35 (1): 27-41. ( DOI )

  10. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force 2022.08; 13 (1): ( DOI )

  11. Marked increase of interferon-β after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy 2022.03; 15 (3): ( DOI )

  12. Predicting recurrence of respiratory failure in critically ill patients with COVID-19: A preliminary study. 2021.05; 82 (5): e33-e35. ( PubMed, DOI )

  13. Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan. 2021.02; 13 (2): ( PubMed, DOI )

  14. Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review 2020.07; 4 (2): 1-8. ( DOI )

▼display all

Conference Activities & Talks 【 display / non-display

  1. Rinka Ota,Yuta Yamaguchi,Hiroko Iwamura,Tomoyuki Furuyashiki. 社会的敗北ストレスによる好中球機能の変化. 第68 回 日本神経化学会大会 2025.09.12

  2. Yamaguchi Yuta, Kato Yasuhiro, Kumanogoh Atsushi. BNT162b2 mRNAワクチンの連続接種により自然免疫系にTLR4寛容が誘導される(Consecutive BNT162b2 mRNA vaccination induces TLR4 tolerance in the innate immune system). 日本免疫学会総会・学術集会記録 2023.12.01

  3. Edahiro Ryuya, Shirai Yuya, Takeshima Yusuke, Sakakibara Shuhei, Yamaguchi Yuta, Murakami Teruaki, Morita Takayoshi, Kato Yasuhiro, Tomofuji Yoshihiko, Okuzaki Daisuke, Kumanogoh Atsushi, Okada Yukinori. 日本人148人を対象としたマルチモーダルシングルセルRNAシークエンシングにより同定されたCOVID-19重症化における自然免疫細胞の病態生理学的・宿主遺伝学的な関与(Multimoal single-cell RNA-sequencing in 148 Japanese identified pathophysiological and host genetic involvement of innate immune cells in COVID-19 severity). 日本免疫学会総会・学術集会記録 2023.12.01

  4. Yamaguchi Yuta, Kato Yasuhiro, Kumanogoh Atsushi. 自然免疫(1) 自然炎症と疾患 BNT162b2 mRNAワクチンにより誘導された単球の短期エピジェネティックメモリー(Innate immunity(1) Innate inflammation and disease Short-term epigenetic memory in monocytes induced by BNT162b2 mRNA vaccine). 日本免疫学会総会・学術集会記録 2022.11.01